Valuation: Kenvue Inc.

Market Cap 36.73B 32.18B 29.88B 27.45B 51.73B 3,544B 52.49B 356B 139B 1,734B 138B 135B 5,991B P/E 2026 *
20.1x
P/E 2027 * 17.9x
Enterprise Value 44.14B 38.67B 35.9B 32.99B 62.16B 4,259B 63.08B 428B 167B 2,084B 166B 162B 7,199B EV / Sales 2026 *
2.82x
EV / Sales 2027 * 2.72x
Free-Float
98.9%
Yield 2026 *
4.43%
Yield 2027 * 4.53%
1 day+0.63%
1 week+2.30%
Current month+0.10%
1 month+7.11%
3 months+10.51%
6 months+7.77%
Current year+10.90%
1 week 18.78
Extreme 18.78
19.36
1 month 18.46
Extreme 18.46
20.13
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
22.87
3 years 14.02
Extreme 14.02
25.23
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
6/29/26
Starboard Value LP
OtherCompany 1,413 0.0001%
6/29/26 Free

Director

1,413 0.0001%
6/10/26 Sell

Chief Financial Officer

-3,700 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.63%+2.30%-15.62%-20.32% 36.73B
+0.70%+0.73%-5.80%-2.48% 347B
-2.16%-2.33%-9.56%+0.04% 133B
+1.25%+0.17%+3.30%+18.71% 73.32B
+0.33%+3.02%-11.78%-16.22% 52.46B
+0.32%+0.39%-7.16%-54.01% 29.9B
-0.80%-2.33%-29.70%-32.03% 19.63B
-1.96%+1.18%+11.12%+6.34% 19.62B
-0.19%-1.86%-3.99%+23.01% 17.91B
-0.95%+0.09%-14.11%+2.14% 11.33B
Average -0.75%+0.78%-8.33%-7.48% 74.11B
Weighted average by Cap. -1.15%+0.88%-6.81%-3.73%

Financials

2026 *2027 *
Net sales 15.63B 13.69B 12.71B 11.68B 22.01B 1,508B 22.33B 151B 59.26B 738B 58.66B 57.39B 2,549B 16.02B 14.04B 13.03B 11.98B 22.57B 1,546B 22.9B 155B 60.76B 756B 60.14B 58.85B 2,613B
Net income 1.84B 1.61B 1.5B 1.38B 2.6B 178B 2.63B 17.86B 6.99B 87.01B 6.92B 6.77B 301B 2.06B 1.81B 1.68B 1.54B 2.91B 199B 2.95B 20.01B 7.83B 97.49B 7.75B 7.58B 337B
Net Debt 7.41B 6.49B 6.02B 5.54B 10.43B 715B 10.59B 71.77B 28.09B 350B 27.8B 27.2B 1,208B 6.81B 5.97B 5.54B 5.09B 9.59B 657B 9.73B 66B 25.83B 322B 25.57B 25.02B 1,111B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-07-22 US$19.13 +0.63% 9,899,890
26-07-21 US$19.01 -0.05% 12,703,960
26-07-20 US$19.02 +0.21% 12,222,234
26-07-17 US$18.98 -0.21% 29,311,427
26-07-16 US$19.02 +1.71% 15,950,710
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.13USD
Average target price
19.83USD
Spread / Average Target
+3.68%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock